A study analyzing the price performance of publicly traded biotech stocks following the announcement of phase two and/or phase three clinical trial results.
We will be presenting an overview of the study here so investors may see what it looks like in progress. The study will be updated on an ongoing basis.
The results may provide investors with information on investing in biotech stocks following clinical trial results. Our investment research process is based on factual information for the purpose of consistent decision making designed to manage risk and achieve out performance.
Implication for stock selection and managing a portfolio: Not useful.
For investors who manage their own portfolio
Investor Boot Camp conducts real time and historical studies for the purpose of objective evidence based input in the investment management process. Study results are incorporated into a systematic markets analysis and portfolio management process. Investors who manage their own portfolio use the research and portfolio guidance to maximize performance while minimizing unnecessary risk.